-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIOTHERAPEUTICS INC - PROCEEDS TO FUND PHASE 2B STUDY FOR SAB-142 IN T1D

Reuters·07/21/2025 11:30:00

Please log in to view news